Zoetis Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Zoetis Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$109Over the last 3 years, every $100 of reported profit came with $109 of operating cash.
Lower than 78% of Healthcare companies in United States.
Self-Funding Ratio
4.1×Over the last 3 years its own operating cash covered its investment spending (capex) 4.1 times.
Higher than 83% of Healthcare companies in United States.
Cash Locked Ratio
$33For every $100 of sales, $33 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $35 tied up three years earlier.
More money tied up than 72% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$40Sales grew 17% in 3 years; of every extra $100 of sales, $40 became extra profit.
Higher than 64% of Healthcare companies in United States.
Asset Productivity Ratio
+17% / +4%In 3 years sales changed by +17% while total assets changed by +4%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
−20%Debt, after subtracting cash, equals 20% of its market value (net debt).
Lower than 84% of Healthcare companies in United States.
Tangible Assets Ratio
76%Of every $100 the company owns, $76 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 77% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Zoetis Inc. owes $0.79 for every $1 it owns. Net profit rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
13.5Investors pay $13.5 for every $1 of Zoetis Inc.'s yearly profit, lower than 77% of Healthcare companies in United States.
P/B ratio
10.76The share price is 10.76 times Zoetis Inc.'s book value per share, higher than 87% of Healthcare companies in United States.
Market cap
$33.9 BThe total market value of all of Zoetis Inc.'s shares at today's price (share price × number of shares), larger than 95% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$3.1 BWhat Zoetis Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$7.62Net worth divided by the number of shares. The share price of $82.00 is 10.8 times this, which is the P/B above.
Return on equity (ROE)
64.9%Zoetis Inc. earned 64.9% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
Owes vs Owns
0.79×Zoetis Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Dividend yield
2.66%Zoetis Inc. pays 2.66% of its share price as dividends a year, higher than 89% of dividend-paying Healthcare companies in United States.
Revenue growth
+2%Revenue rose 2% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Profit growth
+8%Net profit rose 8% in the year to Dec 2025, and grew 8% a year on average over 3 years.
Profit margin
28.2%Zoetis Inc. keeps $28 of every $100 of revenue as net profit.
Cash quality
1.09×Cash from Zoetis Inc.'s business was 1.09× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
16.2×Zoetis Inc.'s operating profit covered its interest costs 16.2 times in the year to Dec 2025.
Cash vs debt
Net debtZoetis Inc. had $6.9 B more debt than cash (net debt) at Dec 2025.
Questions
What is Zoetis Inc.'s P/E ratio?
Investors pay $13.5 for every $1 of Zoetis Inc.'s yearly profit, lower than 77% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Zoetis Inc.: $33.9 B ÷ $3.1 B (30 Jun 2026) = 10.8.
What is Zoetis Inc.'s return on equity?
Zoetis Inc. earned 64.9% on its shareholders' money over the last year, higher than 97% of Healthcare companies in United States.
How much does Zoetis Inc. owe compared with what it owns?
Zoetis Inc. owes $0.79 for every $1 it owns (moderate), higher than 77% of Healthcare companies in United States.
Does Zoetis Inc. pay a dividend?
Yes. Zoetis Inc. pays 2.66% of its share price as dividends a year, higher than 89% of dividend-paying Healthcare companies in United States.
Is Zoetis Inc.'s revenue growing?
Revenue rose 2% in the year to Dec 2025, and grew 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.